Shares of Proteome Sciences plc (LON:PRM – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 3.38 ($0.04) and traded as low as GBX 2.57 ($0.03). Proteome Sciences shares last traded at GBX 2.76 ($0.04), with a volume of 10,000 shares.
Proteome Sciences Price Performance
The business has a fifty day simple moving average of GBX 3 and a 200 day simple moving average of GBX 3.38. The firm has a market cap of £8.00 million, a price-to-earnings ratio of -250.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- The Basics of Support and Resistance
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- There Are Different Types of Stock To Invest In
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Technology Stocks Explained: Here’s What to Know About Tech
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.